Replies to post #182382 on Biotech Values

[biomaven0]

>>very close look at RTRX accounting

Any sort of options screw-up like that referred to above is likely to require a restatement of earnings because the non-cash charges for optins expense will have been wrong. Grants without enough shares become subject to liability accounting - here that could conceivably increase EPS.

Peter